Matthew J. Koster, M.D.  
Assistant Professor of Medicine, Mayo Clinic College of Medicine
Member, Mayo Clinic Vasculitis Center
Recipient, 2016 American College of Rhematology Distinguished Fellow Award
Consultant, Division of Rheumatology

Kenneth J. Warrington, M.D.  
Professor of Medicine, Mayo Clinic College of Medicine
Chair, Division of Rheumatology
Director, Vasculitis Subspecialty Group

Locations:

• Geffen Auditorium (Live)
• Broadcast to SMH Alfred M-459 and MA 17-64
• Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis

Learning Objectives:

• Evaluate and compare advances in diagnostic modalities used in giant cel arteritis
• Review disease course and current treatment options in giant cell arteritis
• Explore evolving and emerging therapeutic options for giant cell arteritis

Financial Disclosure:

• Dr. Warrington - Grant/Research Support: Eli Lilly, GlaxoSmithKline

Off Label/Investigational Uses:

• Dr. Warrington & Dr. Koster - Actemra (Tocilizumab) - Roche-Genentech
• Dr. Koster - Orencia (Abatacept) - Bristol-Meyers-Squibb

Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.